XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash Flows From Operating Activities:    
Net earnings/(loss) $ (10,224) $ 4,344
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization, net 5,128 4,861
Deferred income taxes (1,042) (1,634)
Stock-based compensation 258 259
Impairment charges 871 67
Divestiture gains and royalties (550) (417)
Acquired IPRD 13,081 233
Equity investment (gains)/losses (209) 213
Other adjustments 20 (9)
Changes in operating assets and liabilities:    
Receivables (540) (240)
Inventories (443) (298)
Accounts payable 41 22
Rebates and discounts 70 (418)
Income taxes payable (1,033) (1,235)
Other (268) (891)
Net cash provided by operating activities 5,160 4,857
Cash Flows From Investing Activities:    
Sale and maturities of marketable debt securities 822 327
Purchase of marketable debt securities (358) (555)
Proceeds from sales of equity investments 60 67
Capital expenditures (546) (537)
Divestiture and other proceeds 511 421
Acquisition and other payments, net of cash acquired (21,426) (262)
Net cash used in investing activities (20,937) (539)
Cash Flows From Financing Activities:    
Proceeds from issuance of short-term debt obligations 2,987 0
Repayments of short-term debt obligations (2,731) 0
Other short-term financing obligations, net 409 243
Proceeds from issuance of long-term debt 12,883 0
Repayments of long-term debt (395) (1,879)
Repurchase of common stock 0 (1,155)
Dividends (2,429) (2,393)
Stock option proceeds and other, net (103) (39)
Net cash provided by/(used in) financing activities 10,621 (5,223)
Effect of exchange rates on cash, cash equivalents and restricted cash (67) 5
Decrease in cash, cash equivalents and restricted cash (5,223) (900)
Cash, cash equivalents and restricted cash at beginning of period 11,519 9,325
Cash, cash equivalents and restricted cash at end of period $ 6,296 $ 8,425